keyword
MENU ▼
Read by QxMD icon Read
search

methotrexate pneumonitis

keyword
https://www.readbyqxmd.com/read/27693175/esophageal-abnormalities-in-juvenile-localized-scleroderma-is-it-associated-with-other-extracutaneous-manifestations
#1
Clarissa C M Valões, Glaucia V Novak, Juliana B Brunelli, Katia T Kozu, Ricardo K Toma, Clovis A Silva
OBJECTIVE: To assess esophageal involvement (EI) in juvenile localized scleroderma (JLS) population and the possible association between this gastrointestinal manifestation and demographic data, clinical features, laboratory exams, treatments and outcomes. METHODS: For a period of 31 years, 5,881 patients with rheumatic diseases were followed in our Pediatric Rheumatology Division. EI was defined by the presence of symptoms (solid/liquid dysphagia, heartburn, esophageal regurgitation, nausea/vomiting and epigastralgia) and confirmed by at least one EI exam abnormality: barium contrast radiography, upper gastrointestinal endoscopy and 24-hour esophageal pH-monitoring...
September 17, 2016: Revista Brasileira de Reumatologia
https://www.readbyqxmd.com/read/27307501/inflammatory-arthritis-and-sicca-syndrome-induced-by-nivolumab-and-ipilimumab
#2
Laura C Cappelli, Anna Kristina Gutierrez, Alan N Baer, Jemima Albayda, Rebecca L Manno, Uzma Haque, Evan J Lipson, Karen B Bleich, Ami A Shah, Jarushka Naidoo, Julie R Brahmer, Dung Le, Clifton O Bingham
OBJECTIVES: Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) pathways have demonstrated survival improvements in multiple advanced cancers, but also cause immune-related adverse events (IRAEs). IRAEs with clinical features similar to rheumatic diseases have not been well described. We report patients with inflammatory arthritis and sicca syndrome secondary to ICIs. METHODS: We report patients evaluated in the Johns Hopkins Rheumatology clinics from 2012 to 2016 identified as having new rheumatological symptoms in the context of treatment with ipilimumab (anti-CTLA-4) and/or nivolumab (anti-PD-1) for solid tumours...
June 15, 2016: Annals of the Rheumatic Diseases
https://www.readbyqxmd.com/read/26602361/acute-pneumonitis-in-a-patient-with-adult-onset-disease-after-toclizumab-treatment-with-good-response-to-anakinra
#3
Clara Sangüesa Gómez, Bryan Josué Flores Robles, Beatriz Jara Chinarro, María Espinosa Malpartida, Carmen Barbadillo Mateos
Pulmonary involvement in the form of acute pneumonitis in adult-onset Still's disease (AOSD) is an uncommon manifestation, with few cases reported in the literature. We report the case of a 61-year-old male with 3 years of AOSD evolution, treated with methotrexate (MTX) and half-dose corticosteroids, which debuted with symptoms of fever, dyspnea and dry cough after 3 weeks of receiving the first dose of tocilizumab (TCZ). In the follow-up study showed leukocytosis with left shift, elevated serum ferritin and C-reactive protein standard...
November 18, 2015: Reumatología Clinica
https://www.readbyqxmd.com/read/26600985/-cervical-aspergillosis-with-dissemination-to-the-central-nervous-system-case-reports-and-review-of-the-literature
#4
Guillermo Enrique Vergara, Natalia Roura, Marcelo Del Castillo, Andrea Mora, Santiago Condomi Alcorta, Rubén Mormandi, Andrés Cervio, Jorge Salvat
BACKGROUND: Invasive aspergillosis (IA) of the central nervous system (CNS) is an uncommon condition that usually occurs in immunocompromised patients. This illness can manifest as meningitis, or as a micotic aneurism, stroke or abscess. The infection affects the CNS either primarily or, more often, secondarily via blood dissemination from a distant focus, and has a poor prognosis. We present a patient with IA primarily affecting the cervical bones, with later spread into the brain. CASE DESCRIPTION: A 25-year old male was receiving chemotherapy for acute lymphocytic leukemia when he developed pneumonitis secondary to methotrexate and was started on corticosteroids...
2015: Surgical Neurology International
https://www.readbyqxmd.com/read/26592712/hyperacute-methotrexate-pneumonitis-in-a-patient-with-crohn-s-disease
#5
Itishree Trivedi, Rishi Raj, Stephen Hanauer
No abstract text is available yet for this article.
March 2016: Clinical Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/26526669/the-development-of-a-questionnaire-to-evaluate-rheumatoid-arthritis-patient-s-knowledge-about-methotrexate
#6
Françoise Fayet, Carine Savel, Malory Rodere, Bruno Pereira, Dihya Abdi, Sylvain Mathieu, Anne Tournadre, Martin Soubrier, Jean-Jacques Dubost
AIMS AND OBJECTIVES: Assess knowledge concerning methotrexate in rheumatoid arthritis patients by means of a questionnaire. BACKGROUND: Methotrexate is the standard drug for rheumatoid arthritis treatment. It has potentially serious side effects that can be largely prevented by making sure that patients are well informed and comply with prescription guidelines. DESIGN: Cross-sectional survey. METHODS: A questionnaire on methotrexate (mode of action, administration, drug interactions), side effects, monitoring and lifestyle implications was offered to all the rheumatoid arthritis patients treated with the drug seen between March and September 2013 in a large hospital in France...
March 2016: Journal of Clinical Nursing
https://www.readbyqxmd.com/read/26312671/combined-acute-interstitial-pneumonitis-and-pancytopenia-induced-by-low-dose-methotrexate-in-a-hemodialysis-patient-treated-for-bullous-pemphigoid
#7
Haibo Liu, Fang Liu, Min Zhang, Wenliang Yan, Hong Sang
Methotrexate has been widely used for many years in the treatment of a variety of diseases. Acute pneumonitis and bone marrow suppression are very serious side effects in methotrexate treatment. A 48-year-old man with end-stage renal disease undergoing chronic hemodialysis developed combined acute pneumonitis and pancytopenia after a cumulative dose of 20 mg methotrexate for bullous pemphigoid. Continuous renal replacement therapy (CRRT) can efficiently decrease serum methotrexate concentration. A rapid improvement of clinical symptoms and resolution of pulmonary opacification were found after CRRT...
May 2015: Anais Brasileiros de Dermatologia
https://www.readbyqxmd.com/read/26199244/-transplant-related-mortality-following-allogeneic-hematopoietic-stem-cell-transplantation-using-fludarabine-busulfan-based-reduced-intensity-conditioning-a-retrospective-analysis-in-a-single-institution
#8
Takashi Yoshida, Shigeru Kusumoto, Arisa Masuda, Haruhito Totani, Tomoko Narita, Ayako Masaki, Asahi Ito, Masaki Ri, Takashi Ishida, Hirokazu Komatsu, Shinsuke Iida
Reduced-intensity conditioning (RIC) has been shown to facilitate allogeneichematopoieticstem cell transplantation (allo-HSCT) for patients with comorbidities and the elderly. However, there are some concerns about transplant-related mortality (TRM). We retrospectively analyzed 37 consecutive patients who received allo-HSCT using RIC from January 2005 to December 2012 in our hospital. All patients received fludarabine(FLU), 180 mg/m2, and intravenous busulfan(BU), 6.4 mg/ kg (or oral BU 8 mg/kg), with or without TBI (2 or 4 Gy)...
June 2015: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://www.readbyqxmd.com/read/26069917/-rheumatoid-arthritis-and-lung-more-than-a-minor-aspect-of-the-disease
#9
Christoph Fiehn
Although rheumatoid arthritis (RA) mainly manifests as polyarthritis, there is growing evidence that the initiation of the pathological immune reaction against citrullinated peptides takes place in the lung. However, in spite of this important role of the lung in pathophysiology, clinically manifest lung involvement has been demonstrated only in about 2-5 % of the patients with RA, and therefore is relatively rare. In particular the severe interstitial lung involvement with histological pattern of usual interstitial pneumonia has a bad prognosis and an increased mortality...
June 2015: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/25819619/treatment-for-metastatic-penile-cancer-after-first-line-chemotherapy-failure-analysis-of-response-and-survival-outcomes
#10
Jennifer Wang, Curtis A Pettaway, Lance C Pagliaro
OBJECTIVE: To retrospectively estimate the efficacy of various treatments used in men with metastatic penile cancer that progresses after first-line chemotherapy. METHODS: Patients were from a 30-patient cohort with stage TxN2-3M0 penile squamous cell carcinoma treated with neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy before planned lymphadenectomy. Nineteen patients (63.3%) had tumor progression or recurrence, and we evaluated the response to subsequent treatment and survival...
May 2015: Urology
https://www.readbyqxmd.com/read/25267808/late-onset-methotrexate-induced-pneumonitis-with-neutrophilia-in-bronchoalveolar-lavage-fluid
#11
Hideaki Yamakawa, Masahiro Yoshida, Masamichi Takagi, Kazuyoshi Kuwano
A 61-year-old woman being treated with methotrexate (MTX) 8-10 mg/week and prednisolone 2.5 mg/day for rheumatoid arthritis presented with a 1-week history of increasing fever and dry cough. The patient deteriorated with administration of antibiotics. Chest CT scan showed bilateral diffuse ground-glass opacities. Analysis of bronchoalveolar lavage fluid (BALF) revealed marked neutrophilia (65.2% of total cells). The specimen from transbronchial lung biopsy showed a non-specific interstitial pneumonia pattern...
2014: BMJ Case Reports
https://www.readbyqxmd.com/read/24923536/reduced-intensity-conditioning-hematopoietic-cell-transplantation-is-an-effective-treatment-for-patients-with-slam-associated-protein-deficiency-x-linked-lymphoproliferative-disease-type-1
#12
Rebecca A Marsh, Jack J Bleesing, Shanmuganathan Chandrakasan, Michael B Jordan, Stella M Davies, Alexandra H Filipovich
X-linked lymphoproliferative disease type 1 (XLP1) is a rare immune deficiency caused by mutations in SH2D1A. Allogeneic hematopoietic cell transplantation (HCT) is often performed because of the morbidity and mortality associated with XLP1. There is limited experience using reduced-intensity conditioning (RIC) regimens for these patients. Here we report our 8-year single-center experience. Sixteen consecutive patients diagnosed with XLP1 underwent allogeneic HCT between 2006 and 2013 after a RIC regimen consisting of alemtuzumab, fludarabine, and melphalan...
October 2014: Biology of Blood and Marrow Transplantation
https://www.readbyqxmd.com/read/24892681/life-threatening-pneumonitis-complicating-low-dose-methotrexate-treatment-for-juvenile-idiopathic-arthritis-in-a-child
#13
Yuan-Chang Liu, Yu-Ling Tu, Ren-Chin Wu, Jing-Long Huang, Tsung-Chieh Yao
Methotrexate, a drug commonly used to treat juvenile idiopathic arthritis (JIA), has been reported to cause interstitial pneumonitis as a rare complication in adults with rheumatoid arthritis. Only 1 suspicious case of methotrexate pneumonitis in a child with JIA has been reported in 1998, though with no histopathologic proof. Given its rarity and nonspecific presenting symptoms, diagnosis may be challenging, and a life-threatening illness can occur without a high index of suspicion, as illustrated by this report of a 13-year-old girl with JIA who developed fever, nonproductive cough, and dyspnea as presenting features of interstitial pneumonitis after 1 year of methotrexate therapy...
June 2014: Pediatric Emergency Care
https://www.readbyqxmd.com/read/24757133/methotrexate-and-lung-disease-in-rheumatoid-arthritis-a-meta-analysis-of-randomized-controlled-trials
#14
Richard Conway, Candice Low, Robert J Coughlan, Martin J O'Donnell, John J Carey
OBJECTIVE: Methotrexate has shown efficacy for the treatment of several diseases, especially rheumatoid arthritis (RA). Methotrexate has also been implicated as a causative agent in interstitial lung disease. Patients with RA may develop pulmonary manifestations of their disease and are at increased risk of respiratory infection. The aim of this study was to evaluate the relative risk (RR) of pulmonary disease among patients with RA treated with methotrexate. METHODS: We searched the PubMed and Cochrane databases (publication dates January 1, 1990 to February 1, 2013) for double-blind, randomized, controlled trials of methotrexate versus placebo or active comparator agents in adults with RA...
April 2014: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/24646908/pneumonitis-due-to-cytomegalovirus-during-chronic-methotrexate-treatment
#15
Marco Aurelio Ramírez Huaranga, Erika Bencosme de Mendez, José Luis Cuadra Díaz, Javier Lázaro Polo, Carlos Bujalance Cabrera
Although hypersensitivity pneumonitis is the most common pulmonary complication described during treatment with methotrexate, other complications like lymphoproliferative and infectious disease may be considered in the study of respiratory disease associated to methotrexate. The existence of an increased risk to developing infectious diseases may be similar to that observed during treatment with antagonists of tumor necrosis factor and corticosteroids, where Cytomegalovirus pneumonia is a serious complication; early diagnosis and treatment will prevent a potentially fatal outcome...
September 2014: Reumatología Clinica
https://www.readbyqxmd.com/read/24444433/methotrexate-induces-production-of-il-1-and-il-6-in-the-monocytic-cell-line-u937
#16
Nancy J Olsen, Charles F Spurlock, Thomas M Aune
INTRODUCTION: Methotrexate (MTX) has been for decades a standard treatment in a wide range of conditions, from malignancies to rheumatoid arthritis (RA). Despite this long experience, the mechanisms of action of MTX remain incompletely understood. Reported immunologic effects of MTX include induction of increased production of some cytokines, an effect that seems to be at odds with the generally anti-inflammatory effects of this drug in diseases like RA. To further elucidate these immune activities, we examined effects of MTX on the human monocytic cell line U937...
2014: Arthritis Research & Therapy
https://www.readbyqxmd.com/read/24374778/methotrexate-and-lung-disease-in-rheumatoid-arthritis-a-meta-analysis-of-randomized-controlled-trials
#17
Richard Conway, Candice Low, Robert J Coughlan, Martin J O'Donnell, John J Carey
Objective Methotrexate has shown efficacy in treating several diseases, especially rheumatoid arthritis (RA). Methotrexate has been implicated as a causative agent in interstitial lung disease. Patients with RA may develop pulmonary manifestations of their disease and are at increased risk of respiratory infections. The aim of this study was to evaluate the relative risk of pulmonary disease among RA patients treated with methotrexate. Methods We searched Pubmed and Cochrane databases between 1(st) January 1990 and 1(st) February 2013 for double-blind randomised controlled trials of methotrexate versus placebo or active comparator agents in adults with RA...
December 24, 2013: Arthritis and Rheumatism
https://www.readbyqxmd.com/read/24372368/methotrexate-induced-pneumonitis-heterogeneity-of-bronchoalveolar-lavage-and-differences-between-cancer-and-rheumatoid-arthritis
#18
REVIEW
Tommaso D'Elia
PURPOSE: Our knowledge on bronchoalveolar lavage (BAL) of methotrexate-induced pneumonitis (MTX-P) is fragmentary and based on data that are sometimes apparently conflicting. Aim of this review was to provide a comprehensive overview on the BAL features of MTX-P arising from cases published to date, and to determine the cytological patterns and any differences between cancer and rheumatoid arthritis patients, the two patient subsets among which this complication more often occurs. METHODS: English-language articles published up to November 2013 were systematically searched through PUBMED, EMBASE, and other databases...
February 2014: Inflammation & Allergy Drug Targets
https://www.readbyqxmd.com/read/24231065/interstitial-lung-diseases-induced-or-exacerbated-by-dmards-and-biologic-agents-in-rheumatoid-arthritis-a-systematic-literature-review
#19
REVIEW
Camille Roubille, Boulos Haraoui
OBJECTIVE: To review published cases of induced or exacerbated interstitial lung disease (ILD) in rheumatoid arthritis (RA) associated with non-biologic disease-modifying antirheumatic drugs (nbDMARDs) and biologics and to discuss clinical implications in daily practice. METHODS: We performed a systematic literature review from 1975 to July 2013 using Medline, Embase, Cochrane, and abstracts from the ACR 2010-2012 and EULAR 2010-2013 annual meetings. Case reports and series that suggest a causative role of nbDMARDs (methotrexate [MTX], leflunomide [LEF], gold, azathioprine [AZA], sulfasalazine [SSZ], and hydroxychloroquine [HCQ]) and biologic agents (TNF inhibitors [TNFi], rituximab [RTX], tocilizumab [TCZ], abatacept [ABA], and anakinra) in causing ILD or worsening a pre-existing ILD in RA patients were included...
April 2014: Seminars in Arthritis and Rheumatism
https://www.readbyqxmd.com/read/23899235/lung-involvement-and-drug-induced-lung-disease-in-patients-with-rheumatoid-arthritis
#20
REVIEW
Fabiola Atzeni, Luigi Boiardi, Salvatore Sallì, Maurizio Benucci, Piercarlo Sarzi-Puttini
Interstitial lung disease (ILD) is a common extra-articular manifestation of rheumatoid arthritis (RA) and a significant cause of morbidity and mortality. Usual interstitial pneumonia and nonspecific interstitial pneumonia seem to be the most frequent patterns in RA patients with ILD, although the proportion of patients with usual interstitial pneumonia is higher than among patients with other systemic rheumatic autoimmune diseases. RA patients with ILD most frequently present with chronic symptoms of cough and dyspnea when climbing stairs or walking uphill...
July 2013: Expert Review of Clinical Immunology
keyword
keyword
40195
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"